Home » Industry Sees Patient Risks in UK Off-Label Guidance
Industry Sees Patient Risks in UK Off-Label Guidance
UK industry stakeholders are raising concerns over the General Medical Council’s (GMC) proposed guidance on prescribing off-label or unlicensed medical products.
International Medical Device Regulatory Monitor
International Medical Device Regulatory Monitor
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May